• Follow the Money: GPCR Targets, Upacicalcet, AAV-Delivered Cancer Immunotherapy, More

    Clinical Research News | Superluminal Medicines is focusing on supporting the progression of their lead program into clinical development and increase the number of small molecule drug discovery programs focused on high-value G protein-coupled receptor (GPCR) targets; Pathalys Pharma wraps up upacicalcet clinical trials; Vironexis anticipates initiating patient enrollment of a Phase 1/2 trial of VNX-101 in the fourth quarter of 2024, which will mark the first-ever clinical trial of an AAV-delivered cancer immunotherapy; and more.

    Sep 26, 2024

  • AstraZeneca, Moffitt Cancer Center Partner, Firefly Neuroscience Advances AI Tech, More

    Clinical Research News | Moffitt Cancer Center announced a strategic collaboration with AstraZeneca that aims to accelerate the development of cell therapies, specifically chimeric antigen receptor T cell and T cell receptor therapies; Firefly Neuroscience announced the advancement of its artificial intelligence-powered Brain Network Analytics (BNA) technology; and more.

    Sep 25, 2024

  • PCORI Offers $100 Million For Youth Research, Children’s Health Promotion

    Clinical Research News | PCORI announced earlier this month that they are inviting proposals through eight new funding opportunities. These include three PCORI Funding Announcements for patient-centered comparative clinical effectiveness research (CER). Letters of intent are due October 1, 2024, and applications will be accepted until January 14, 2025.

    Sep 24, 2024

  • Flatiron Health Expands its Mission to Make Trials More ‘Pragmatic’

    Clinical Research News | The patient groups more likely to be treated at community practices with limited or no access to oncology clinical trials are the same groups historically underrepresented in such trials, finds a nationwide study conducted by Flatiron Health. The reasons for this are unknown, but the research effectively rules out quality of care and location of the practices.

    Sep 19, 2024

  • Trial Emulation Study Taps Real-World Data to Help Fill Evidence Gaps

    Clinical Research News | Researchers in the UK recently emulated a large, randomized controlled trial (RCT) testing the effectiveness of two blood thinners using data from real-world patients to help understand whether the real-world data can be used to explore treatment effects in people underrepresented in the study. While results of the reference trial and its simulation didn’t entirely align, the approach could help fill the evidence gap for population groups largely missing in RCTs.

    Sep 17, 2024

  • New Treatment Option for Graves’ Disease Finally ‘On the Horizon’

    Clinical Research News | Later this year, Immunovant will be launching a late-stage clinical trial for Graves’ disease—the first in a very, very long time. The preferred treatment option currently is methimazole, approved for medical use in the U.S. in 1950, but some patients require high doses of the drug to control their hyperthyroidism, and in up to half of cases long-term remission isn’t achievable short of surgery to remove the thyroid gland or radioactive iodine to destroy the thyroid and stop it from producing hormones.

    Sep 12, 2024

  • Closing the Gender Diagnostic Gap With a Sample-Collecting Tampon

    Clinical Research News | Women’s health startup Daye is on a mission to bridge the gender diagnostic gap with a tampon for the self-collection of vaginal and cervical fluids analyzed for biomarkers of sexually transmitted infections (STIs), including human papillomavirus (HPV). The tampon is a familiar device used by over 90% of the female population and much better suited to their anatomy than conventional vaginal swabs.

    Sep 10, 2024

  • uMotif Buys ClinOne

    Clinical Research News | uMotif has acquired site platform provider ClinOne. The acquisition is the logical next step in a successful two-year strategic partnership between the companies to leverage a single, integrated solution for electronic clinical outcomes assessments (eCOA) and electronic informed consent (eConsent) technology. Financial details were not released.

    Sep 9, 2024

  • SEQSTER and PatientsLikeMe Partner for Connected Patient Hub With Real-Time EHR Data

    Clinical Research News | SEQSTER and United Healthcare Group’s PatientsLikeMe (PLM) announced their strategic partnership to accelerate the patient screening process, improve the patient onboarding experience to increase retention and engagement, and provide more resources and tools for condition-specific communities.

    Sep 5, 2024